 Shares of COVID-19 vaccine maker Novavax Inc. on Wednesday sank 11 after the company announced a proposed offering to sell millions of its debt and stock. The company said the proceeds could go toward the global launch of its Nuvaxovid COVID vaccine and the repayment or repurchase of some of the 325 million of its convertible debt due in February. 